Gaudium IVF & Women

Q: How strong is Gaudium IVF & Women balance sheet?

Balance sheet of Gaudium IVF & Women is strong.It shouldn't have solvency or liquidity issues.

Q: Is the debt of Gaudium IVF & Women increasing or decreasing?

Yes, The net debt of Gaudium IVF & Women is increasing.Latest net debt of Gaudium IVF & Women is ₹14.29 Crs as of Mar-26.This is greater than Mar-25 when it was ₹11.01 Crs.

Q: Has the share price of Gaudium IVF & Women grown faster than its competition?

There is not enough historical data for the companies share price.

GAUDIUMIVF

Price

-- --

Micro Cap

₹878 Cr.

New to Zerodha? Sign-up for free.

Gaudium IVF and Women Health offers a range of fertility treatments including IVF, IUI, ICSI, Egg Freezing, and laser assisted embryo implantation. The company operates under the regulations of centr… More

Gaudium IVF and Women Health offers a range of fertility treatments including IVF, IUI, ICSI, Egg F… More

Low

69.18

52W Range

High

163

35.89

Sector PE

48.37

P/B

5.76

Div.Yield

ROE

41.31%

EBIDTA

33.93

ROCE

53.59

EPS

0.24

New to Zerodha? Sign-up for free.

Get instant stock alerts

Share Price
Financials
Revenue mix
Shareholdings
Peers
Forensics

Coming soon

Summary
Profit & Loss
Balance sheet
Cashflow

Yearly | Quarterly

View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly

(In Cr.)

(In Cr.)
This data is currently unavailable for this company.

Financial Ratio's

(In %)

Detailed P&L Report

(In Cr.)

Detailed Balance Sheet

Financial Year (In Cr.)

Detailed Cash Flow

Product wise
Location wise

GAUDIUMIVF
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

GAUDIUMIVF
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

More Info

Shareholdings

Holders

Detailed Shareholdings

This data is currently unavailable for this company.

Peers

Detailed Peers

Forensics

View Detailed Forensics

Recent events

News
Corporate Actions

Gaudium IVF And Women Health To Commence Operations At New South Extension, New Delhi Centre On July 16, 2026

Jul 15, 2026

New Hospital Expansion

Jun 25, 2026

Gaudium IVF And Women Health Gets Legal Notice Of 292.1 Million Rupees For Alleged Advisory Services In IPO

Apr 01, 2026

Events:

Lockin Period Expiry (Non-Promoter)

Date

Aug 26, 2026

Quarterly Results

Announcement Date

Aug 13, 2026

Quarterly Results

Announcement Date

May 28, 2026

Lockin Period Expiry (Anchor)

Date

May 26, 2026

Lockin Period Expiry (Anchor)

Date

Mar 26, 2026

Quarterly Results

Announcement Date

Mar 18, 2026

More Micro Cap Ideas

See similar 'Micro' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Detailed List

Capex

Companies investing on expansion

Detailed List

Superstar Investor

Companies where well known investors have invested

Detailed List

Popular questions

Business
Financials
Share Price
Shareholdings

What does Gaudium IVF & Women do?

Gaudium IVF and Women Health is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. The company has patients from different countries such as Canada, United Kingdom, United State, Kenya, South Africa and Oman. The company’s Main centers (Hubs) are located in major cities to cater potential locations across India.

Who are the competitors of Gaudium IVF & Women?

Gaudium IVF & Women major competitors are . Market Cap of Gaudium IVF & Women is ₹878 Crs. While the median market cap of its peers are ₹0 Crs.

Is Gaudium IVF & Women financially stable compared to its competitors?

Gaudium IVF & Women seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Does Gaudium IVF & Women pay decent dividends?

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Gaudium IVF & Women latest dividend payout ratio is 46.95% and 3yr average dividend payout ratio is 46.95%

How has Gaudium IVF & Women allocated its funds?

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

How strong is Gaudium IVF & Women balance sheet?

Balance sheet of Gaudium IVF & Women is strong. It shouldn't have solvency or liquidity issues.

Is the profitablity of Gaudium IVF & Women improving?

The profit is oscillating. The profit of Gaudium IVF & Women is ₹16.84 Crs for TTM, ₹19.13 Crs for Mar 2025 and ₹10.32 Crs for Mar 2024.

Is the debt of Gaudium IVF & Women increasing or decreasing?

Yes, The net debt of Gaudium IVF & Women is increasing. Latest net debt of Gaudium IVF & Women is ₹14.29 Crs as of Mar-26. This is greater than Mar-25 when it was ₹11.01 Crs.

Is Gaudium IVF & Women stock expensive?

Gaudium IVF & Women is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Gaudium IVF & Women is 35.89, while 3 year average PE is 36.93. Also latest EV/EBITDA of Gaudium IVF & Women is 33.93 while 3yr average is 28.42.

Has the share price of Gaudium IVF & Women grown faster than its competition?

There is not enough historical data for the companies share price.

Is the promoter bullish about Gaudium IVF & Women?

Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Gaudium IVF & Women is 71.29% and last quarter promoter holding is 71.29%.

Are mutual funds buying/selling Gaudium IVF & Women?

There is Insufficient data to gauge this.

Gaudium IVF & Women

Share Price

Financials

Summary

Profit & Loss

Balance sheet

Cashflow

Revenue mix

Product wise

Location wise

Shareholdings

Peers

Forensics

Recent events

News

Corporate Actions

More Micro Cap Ideas

Promoter Buying

Capex

Superstar Investor

Popular questions

What does Gaudium IVF & Women do?

Who are the competitors of Gaudium IVF & Women?

Is Gaudium IVF & Women financially stable compared to its competitors?

Does Gaudium IVF & Women pay decent dividends?

How has Gaudium IVF & Women allocated its funds?

How strong is Gaudium IVF & Women balance sheet?

Is the profitablity of Gaudium IVF & Women improving?

Is the debt of Gaudium IVF & Women increasing or decreasing?

Is Gaudium IVF & Women stock expensive?

Has the share price of Gaudium IVF & Women grown faster than its competition?

Is the promoter bullish about Gaudium IVF & Women?

Are mutual funds buying/selling Gaudium IVF & Women?